Fulcrum Capital Group

Fulcrum pursues control and significant minority equity positions in middle-market companies that benefit from trans-Pacific expansion. The firm uses its teams in Los Angeles, San Francisco, Shanghai, Beijing, and Shenzhen to provide operational resources and market access on both sides of the Pacific. The strategy emphasizes sectors where US-China supply-chain integration creates durable competitive advantages.

Fulcrum's capital base is not publicly disclosed. The firm operates as a private investment manager rather than a registered family office, and it has not published limited-partner composition or fund structure details. Allocators evaluating the manager should request LP references and fund documentation directly.

The firm's five-office structure suggests deal flow originates through its permanent in-region teams rather than through intermediaries. Fulcrum's China-based professionals likely cultivate relationships with domestic founders and industrial groups, while US-based partners identify North American targets with Asia expansion potential. The firm has not publicly disclosed a preferred sourcing channel or minimum investment threshold.

Fulcrum has not published a sector exclusion list or negative-screen policy. Based on the limited public record of its portfolio activity, the firm concentrates on enterprise technology, advanced manufacturing, and healthcare services. Allocators conducting operational due diligence should confirm the firm's current committee on foreign investment and sanctions compliance posture given its cross-border mandate.

There is no public record of Fulcrum being a spinout from or affiliate of another named investment manager. The firm's cross-border architecture resembles structures used by several pan-Asian single-family offices, but Fulcrum itself has not disclosed any family-office lineage. Direct inquiry with the firm is advisable for confirmation.